Global Pediatric Vaccines Market Research Report 2020

Global Pediatric Vaccines Market Research Report 2020

Table of Contents
1 Pediatric Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Vaccines
1.2 Pediatric Vaccines Segment by Type
1.2.1 Global Pediatric Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Pediatric Vaccines Segment by Application
1.3.1 Pediatric Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Global Pediatric Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Vaccines Revenue 2015-2026
1.4.2 Global Pediatric Vaccines Sales 2015-2026
1.4.3 Pediatric Vaccines Market Size by Region: 2020 Versus 2026
2 Global Pediatric Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Pediatric Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Pediatric Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Pediatric Vaccines Players (Opinion Leaders)
3 Pediatric Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Pediatric Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Pediatric Vaccines Market Facts & Figures by Country
3.3.1 North America Pediatric Vaccines Sales by Country
3.3.2 North America Pediatric Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Vaccines Market Facts & Figures by Country
3.4.1 Europe Pediatric Vaccines Sales by Country
3.4.2 Europe Pediatric Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Vaccines Sales by Region
3.5.2 Asia Pacific Pediatric Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pediatric Vaccines Market Facts & Figures by Country
3.6.1 Latin America Pediatric Vaccines Sales by Country
3.6.2 Latin America Pediatric Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Vaccines Sales by Country
3.7.2 Middle East and Africa Pediatric Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pediatric Vaccines Historic Market Analysis by Type
4.1 Global Pediatric Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Pediatric Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Pediatric Vaccines Price Market Share by Type (2015-2020)
4.4 Global Pediatric Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Pediatric Vaccines Historic Market Analysis by Application
5.1 Global Pediatric Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Pediatric Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Pediatric Vaccines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Pediatric Vaccines Business
6.1 GlaxoSmithKline
6.1.1 Corporation Information
6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GlaxoSmithKline Products Offered
6.1.5 GlaxoSmithKline Recent Development
6.2 Merck
6.2.1 Merck Pediatric Vaccines Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Pfizer
6.3.1 Pfizer Pediatric Vaccines Production Sites and Area Served
6.3.2 Pfizer Description, Business Overview and Total Revenue
6.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Pfizer Products Offered
6.3.5 Pfizer Recent Development
6.4 Sanofi
6.4.1 Sanofi Pediatric Vaccines Production Sites and Area Served
6.4.2 Sanofi Description, Business Overview and Total Revenue
6.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.4.5 Sanofi Recent Development
6.5 AstraZeneca
6.5.1 AstraZeneca Pediatric Vaccines Production Sites and Area Served
6.5.2 AstraZeneca Description, Business Overview and Total Revenue
6.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 AstraZeneca Products Offered
6.5.5 AstraZeneca Recent Development
6.6 Novartis
6.6.1 Novartis Pediatric Vaccines Production Sites and Area Served
6.6.2 Novartis Description, Business Overview and Total Revenue
6.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Novartis Products Offered
6.6.5 Novartis Recent Development
6.7 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Pediatric Vaccines Production Sites and Area Served
6.6.2 Takeda Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Takeda Pharmaceutical Products Offered
6.7.5 Takeda Pharmaceutical Recent Development
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Pediatric Vaccines Production Sites and Area Served
6.8.2 Bavarian Nordic Description, Business Overview and Total Revenue
6.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Bavarian Nordic Products Offered
6.8.5 Bavarian Nordic Recent Development
6.9 Baxter
6.9.1 Baxter Pediatric Vaccines Production Sites and Area Served
6.9.2 Baxter Description, Business Overview and Total Revenue
6.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Baxter Products Offered
6.9.5 Baxter Recent Development
6.10 LG Life Sciences
6.10.1 LG Life Sciences Pediatric Vaccines Production Sites and Area Served
6.10.2 LG Life Sciences Description, Business Overview and Total Revenue
6.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 LG Life Sciences Products Offered
6.10.5 LG Life Sciences Recent Development
6.11 Lupin
6.11.1 Lupin Pediatric Vaccines Production Sites and Area Served
6.11.2 Lupin Pediatric Vaccines Description, Business Overview and Total Revenue
6.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Lupin Products Offered
6.11.5 Lupin Recent Development
6.12 S K Chemicals
6.12.1 S K Chemicals Pediatric Vaccines Production Sites and Area Served
6.12.2 S K Chemicals Pediatric Vaccines Description, Business Overview and Total Revenue
6.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 S K Chemicals Products Offered
6.12.5 S K Chemicals Recent Development
6.13 Mitsubishi Tanabe Pharma
6.13.1 Mitsubishi Tanabe Pharma Pediatric Vaccines Production Sites and Area Served
6.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Description, Business Overview and Total Revenue
6.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Mitsubishi Tanabe Pharma Products Offered
6.13.5 Mitsubishi Tanabe Pharma Recent Development
6.14 Janssen
6.14.1 Janssen Pediatric Vaccines Production Sites and Area Served
6.14.2 Janssen Pediatric Vaccines Description, Business Overview and Total Revenue
6.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Janssen Products Offered
6.14.5 Janssen Recent Development
6.15 Shenzhen Kangtai Biological Products
6.15.1 Shenzhen Kangtai Biological Products Pediatric Vaccines Production Sites and Area Served
6.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Description, Business Overview and Total Revenue
6.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Shenzhen Kangtai Biological Products Products Offered
6.15.5 Shenzhen Kangtai Biological Products Recent Development
6.16 Sinovac Biotech
6.16.1 Sinovac Biotech Pediatric Vaccines Production Sites and Area Served
6.16.2 Sinovac Biotech Pediatric Vaccines Description, Business Overview and Total Revenue
6.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Sinovac Biotech Products Offered
6.16.5 Sinovac Biotech Recent Development
6.17 Bharat Biotech
6.17.1 Bharat Biotech Pediatric Vaccines Production Sites and Area Served
6.17.2 Bharat Biotech Pediatric Vaccines Description, Business Overview and Total Revenue
6.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Bharat Biotech Products Offered
6.17.5 Bharat Biotech Recent Development
6.18 Crucell
6.18.1 Crucell Pediatric Vaccines Production Sites and Area Served
6.18.2 Crucell Pediatric Vaccines Description, Business Overview and Total Revenue
6.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Crucell Products Offered
6.18.5 Crucell Recent Development
6.19 Dynavax
6.19.1 Dynavax Pediatric Vaccines Production Sites and Area Served
6.19.2 Dynavax Pediatric Vaccines Description, Business Overview and Total Revenue
6.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.19.4 Dynavax Products Offered
6.19.5 Dynavax Recent Development
6.20 Serum Institute of India
6.20.1 Serum Institute of India Pediatric Vaccines Production Sites and Area Served
6.20.2 Serum Institute of India Pediatric Vaccines Description, Business Overview and Total Revenue
6.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.20.4 Serum Institute of India Products Offered
6.20.5 Serum Institute of India Recent Development
7 Pediatric Vaccines Manufacturing Cost Analysis
7.1 Pediatric Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Vaccines
7.4 Pediatric Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Vaccines Distributors List
8.3 Pediatric Vaccines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Pediatric Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Pediatric Vaccines by Type (2021-2026)
10.2 Pediatric Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Pediatric Vaccines by Application (2021-2026)
10.3 Pediatric Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Pediatric Vaccines by Region (2021-2026)
10.4 North America Pediatric Vaccines Estimates and Projections (2021-2026)
10.5 Europe Pediatric Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Pediatric Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Pediatric Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Pediatric Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Pediatric Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Pediatric Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Pediatric Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Pediatric Vaccines Manufacturers Covered in This Study
Table 5. Global Pediatric Vaccines Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Pediatric Vaccines Sales Share by Manufacturers (2015-2020)
Table 7. Global Pediatric Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Pediatric Vaccines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Pediatric Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Pediatric Vaccines Sales Sites and Area Served
Table 11. Manufacturers Pediatric Vaccines Product Types
Table 12. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Vaccines as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Pediatric Vaccines Players
Table 16. Global Pediatric Vaccines Sales (K Units) by Region (2015-2020)
Table 17. Global Pediatric Vaccines Sales Market Share by Region (2015-2020)
Table 18. Global Pediatric Vaccines Revenue (Million US$) by Region (2015-2020)
Table 19. Global Pediatric Vaccines Revenue Market Share by Region (2015-2020)
Table 20. North America Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 21. North America Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 22. North America Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 24. Europe Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 25. Europe Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 26. Europe Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Pediatric Vaccines Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Pediatric Vaccines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Pediatric Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Pediatric Vaccines Revenue Market Share by Region (2015-2020)
Table 32. Latin America Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 33. Latin America Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 34. Latin America Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Pediatric Vaccines Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Pediatric Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country (2015-2020)
Table 40. Global Pediatric Vaccines Sales (K Units) by Type (2015-2020)
Table 41. Global Pediatric Vaccines Sales Share by Type (2015-2020)
Table 42. Global Pediatric Vaccines Revenue (Million US$) by Type (2015-2020)
Table 43. Global Pediatric Vaccines Revenue Share by Type (2015-2020)
Table 44. Global Pediatric Vaccines Price (USD/Unit) by Type (2015-2020)
Table 45. Global Pediatric Vaccines Sales (K Units) by Application (2015-2020)
Table 46. Global Pediatric Vaccines Sales Market Share by Application (2015-2020)
Table 47. Global Pediatric Vaccines Sales Growth Rate by Application (2015-2020)
Table 48. GlaxoSmithKline Pediatric Vaccines Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GlaxoSmithKline Main Product
Table 52. GlaxoSmithKline Recent Development
Table 53. Merck Pediatric Vaccines Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Pfizer Pediatric Vaccines Corporation Information
Table 59. Pfizer Corporation Information
Table 60. Pfizer Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Pfizer Main Product
Table 62. Pfizer Recent Development
Table 63. Sanofi Pediatric Vaccines Corporation Information
Table 64. Sanofi Corporation Information
Table 65. Sanofi Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Sanofi Main Product
Table 67. Sanofi Recent Development
Table 68. AstraZeneca Pediatric Vaccines Corporation Information
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. AstraZeneca Main Product
Table 72. AstraZeneca Recent Development
Table 73. Novartis Pediatric Vaccines Corporation Information
Table 74. Novartis Corporation Information
Table 75. Novartis Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Novartis Main Product
Table 77. Novartis Recent Development
Table 78. Takeda Pharmaceutical Pediatric Vaccines Corporation Information
Table 79. Takeda Pharmaceutical Corporation Information
Table 80. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Takeda Pharmaceutical Main Product
Table 82. Takeda Pharmaceutical Recent Development
Table 83. Bavarian Nordic Pediatric Vaccines Corporation Information
Table 84. Bavarian Nordic Corporation Information
Table 85. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Bavarian Nordic Main Product
Table 87. Bavarian Nordic Recent Development
Table 88. Baxter Pediatric Vaccines Corporation Information
Table 89. Baxter Corporation Information
Table 90. Baxter Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Baxter Main Product
Table 92. Baxter Recent Development
Table 93. LG Life Sciences Pediatric Vaccines Corporation Information
Table 94. LG Life Sciences Corporation Information
Table 95. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. LG Life Sciences Main Product
Table 97. LG Life Sciences Recent Development
Table 98. Lupin Pediatric Vaccines Corporation Information
Table 99. Lupin Corporation Information
Table 100. Lupin Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Lupin Main Product
Table 102. Lupin Recent Development
Table 103. S K Chemicals Pediatric Vaccines Corporation Information
Table 104. S K Chemicals Corporation Information
Table 105. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. S K Chemicals Main Product
Table 107. S K Chemicals Recent Development
Table 108. Mitsubishi Tanabe Pharma Pediatric Vaccines Corporation Information
Table 109. Mitsubishi Tanabe Pharma Corporation Information
Table 110. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Mitsubishi Tanabe Pharma Main Product
Table 112. Mitsubishi Tanabe Pharma Recent Development
Table 113. Janssen Pediatric Vaccines Corporation Information
Table 114. Janssen Corporation Information
Table 115. Janssen Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Janssen Main Product
Table 117. Janssen Recent Development
Table 118. Shenzhen Kangtai Biological Products Pediatric Vaccines Corporation Information
Table 119. Shenzhen Kangtai Biological Products Corporation Information
Table 120. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Shenzhen Kangtai Biological Products Main Product
Table 122. Shenzhen Kangtai Biological Products Recent Development
Table 123. Sinovac Biotech Pediatric Vaccines Corporation Information
Table 124. Sinovac Biotech Corporation Information
Table 125. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Sinovac Biotech Main Product
Table 127. Sinovac Biotech Recent Development
Table 128. Bharat Biotech Pediatric Vaccines Corporation Information
Table 129. Bharat Biotech Corporation Information
Table 130. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Bharat Biotech Main Product
Table 132. Bharat Biotech Recent Development
Table 133. Crucell Pediatric Vaccines Corporation Information
Table 134. Crucell Corporation Information
Table 135. Crucell Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Crucell Main Product
Table 137. Crucell Recent Development
Table 138. Dynavax Pediatric Vaccines Corporation Information
Table 139. Dynavax Corporation Information
Table 140. Dynavax Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. Dynavax Main Product
Table 142. Dynavax Recent Development
Table 143. Serum Institute of India Pediatric Vaccines Corporation Information
Table 144. Serum Institute of India Corporation Information
Table 145. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Serum Institute of India Main Product
Table 147. Serum Institute of India Recent Development
Table 148. Sales Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Pediatric Vaccines Distributors List
Table 151. Pediatric Vaccines Customers List
Table 152. Market Key Trends
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Global Pediatric Vaccines Sales (K Units) Forecast by Type (2021-2026)
Table 156. Global Pediatric Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 157. Global Pediatric Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
Table 158. Global Pediatric Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 159. Global Pediatric Vaccines Sales (K Units) Forecast by Application (2021-2026)
Table 160. Global Pediatric Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
Table 161. Global Pediatric Vaccines Sales (K Units) Forecast by Region (2021-2026)
Table 162. Global Pediatric Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 163. Global Pediatric Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Global Pediatric Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Pediatric Vaccines
Figure 2. Global Pediatric Vaccines Sales Market Share by Type: 2020 VS 2026
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pediatric Vaccines Consumption Market Share by Application: 2020 VS 2026
Figure 10. Newborn
Figure 11. Infant
Figure 12. Child
Figure 13. Dolescent
Figure 14. Global Pediatric Vaccines Market Size 2015-2026 (US$ Million)
Figure 15. Global Pediatric Vaccines Sales Capacity (K Units) (2015-2026)
Figure 16. Global Pediatric Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Pediatric Vaccines Sales Share by Manufacturers in 2020
Figure 18. Global Pediatric Vaccines Revenue Share by Manufacturers in 2019
Figure 19. The Global 5 and 10 Largest Players: Market Share by Pediatric Vaccines Revenue in 2019
Figure 20. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pediatric Vaccines Sales Market Share by Region (2015-2020)
Figure 22. Global Pediatric Vaccines Sales Market Share by Region in 2019
Figure 23. Global Pediatric Vaccines Revenue Market Share by Region (2015-2020)
Figure 24. Global Pediatric Vaccines Revenue Market Share by Region in 2019
Figure 25. North America Pediatric Vaccines Sales Market Share by Country in 2019
Figure 26. North America Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 27. U.S. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 28. U.S. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Canada Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 30. Canada Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Europe Pediatric Vaccines Sales Market Share by Country in 2019
Figure 32. Europe Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 33. Germany Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 34. Germany Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. France Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. France Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. U.K. Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Italy Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 40. Italy Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Russia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 42. Russia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Asia Pacific Pediatric Vaccines Sales Market Share by Region in 2019
Figure 44. Asia Pacific Pediatric Vaccines Revenue Market Share by Region in 2019
Figure 45. China Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. China Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Japan Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. Japan Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. South Korea Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. South Korea Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. India Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. India Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Australia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. Australia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Taiwan Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 56. Taiwan Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Indonesia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 58. Indonesia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Thailand Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 60. Thailand Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Malaysia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 62. Malaysia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Philippines Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. Philippines Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Vietnam Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. Vietnam Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Latin America Pediatric Vaccines Sales Market Share by Country in 2019
Figure 68. Latin America Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 69. Mexico Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. Mexico Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Brazil Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 72. Brazil Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Argentina Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Middle East and Africa Pediatric Vaccines Sales Market Share by Country in 2019
Figure 76. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country in 2019
Figure 77. Turkey Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Saudi Arabia Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 80. Saudi Arabia Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. U.A.E Pediatric Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 82. U.A.E Pediatric Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Sales Market Share of Pediatric Vaccines by Type (2015-2020)
Figure 84. Sales Market Share of Pediatric Vaccines by Type in 2019
Figure 85. Revenue Share of Pediatric Vaccines by Type (2015-2020)
Figure 86. Revenue Market Share of Pediatric Vaccines by Type in 2019
Figure 87. Global Pediatric Vaccines Sales Growth by Type (2015-2020) (K Units)
Figure 88. Global Pediatric Vaccines Sales Market Share by Application (2015-2020)
Figure 89. Global Pediatric Vaccines Sales Market Share by Application in 2019
Figure 90. Global Revenue Share of Pediatric Vaccines by Application (2015-2020)
Figure 91. Global Revenue Share of Pediatric Vaccines by Application in 2020
Figure 92. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. S K Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Janssen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Shenzhen Kangtai Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Sinovac Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Bharat Biotech Total Revenue

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs